These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8833049)

  • 1. Historical overview of the treatment of rheumatoid arthritis with an emphasis on methotrexate.
    Kremer JM
    J Rheumatol Suppl; 1996 Mar; 44():34-7. PubMed ID: 8833049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increases in use of methotrexate since the 1980s.
    Sokka T
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S13-20. PubMed ID: 21044427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landmark papers on the discovery of methotrexate for the treatment of rheumatoid arthritis and other systemic inflammatory rheumatic diseases: a fascinating story.
    Malaviya AN
    Int J Rheum Dis; 2016 Sep; 19(9):844-51. PubMed ID: 27293066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials to establish methotrexate as a therapy for rheumatoid arthritis.
    Coury FF; Weinblatt ME
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S9-12. PubMed ID: 21044426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of rheumatoid arthritis: the historical context.
    Moreland LW; Russell AS; Paulus HE
    J Rheumatol; 2001 Jun; 28(6):1431-52. PubMed ID: 11409142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate: from its introduction to non-oncologic therapeutics to anti-TNF-α.
    Benedek TG
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S3-8. PubMed ID: 21044425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on methotrexate.
    Braun J; Rau R
    Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The methotrexate therapeutic response in rheumatoid arthritis.
    Ortendahl M; Holmes T; Schettler JD; Fries JF
    J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of current strategies in the future treatment of rheumatoid arthritis.
    Weinblatt ME
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():19-23. PubMed ID: 10646485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History of combination therapy of rheumatoid arthritis.
    Paulus HE
    J Rheumatol Suppl; 1996 Mar; 44():38-42. PubMed ID: 8833050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
    Whittle SL; Hughes RA
    Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
    Sokka T; Pincus T
    J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
    Ideguchi H; Ohno S; Ishigatsubo Y
    J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing length of time taking methotrexate in rheumatoid arthritis.
    Ortendahl M; Schettler JD; Fries JF
    J Rheumatol; 2000 May; 27(5):1139-47. PubMed ID: 10813279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug management of early rheumatoid arthritis - 2008.
    Sokka T; Mäkinen H
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
    Visvanathan S; Wagner C; Smolen J; St Clair EW; Hegedus R; Baker D; Keenan G
    Arthritis Rheum; 2006 Sep; 54(9):2840-4. PubMed ID: 16948115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study.
    Galindo-Rodriguez G; Aviña-Zubieta JA; Russell AS; Suarez-Almazor ME
    J Rheumatol; 1999 Nov; 26(11):2337-43. PubMed ID: 10555887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.